PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Nov 10, 2021 · 10-Q · 41 days after period end · 0001140361-21-037345
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$6.96M | -$3.91M | -$5.75M | -$711.21K |
| EPS Diluted | -$0.24 | -$0.21 | -$1.10 | -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end
